Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving iNO responsiveness
- 15 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Perinatology
- Vol. 42 (1), 37-44
- https://doi.org/10.1038/s41372-021-01228-x
Abstract
Objectives To identify distinguishing characteristics of neonates with persistent pulmonary hypertension of the newborn (PPHN) unresponsive to inhaled nitric oxide (iNO) and evaluate the use of milrinone in this cohort. Study design Retrospective chart review of 99 neonates with PPHN treated with iNO over a five-year period at a quaternary neonatal intensive care unit. Results Neonates with iNO-unresponsive PPHN had an increased number of ventilator days (10 vs 7 days, p = 0.02), greater length of hospital stay (30 vs 22 days, p = 0.02), and increased risk of death or ECMO than iNO-responsive neonates (p = 0.03). Inhaled NO non-responders treated with milrinone had improved oxygenation (p < 0.03) and no change in systemic hemodynamics. Conclusion Neonates with iNO-unresponsive PPHN had worse clinical outcomes than iNO responders. Milrinone may be a safe and effective adjuvant therapy, although large-scale studies are lacking. Identifying early predictors of iNO response and novel strategies to enhance iNO responsiveness should be prioritized.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (5R01HL13693)
This publication has 39 references indexed in Scilit:
- Neonatal pulmonary hypertensionPediatric Critical Care Medicine, 2010
- Regulation of Phosphodiesterase 3 in the Pulmonary Arteries During the Perinatal Period in SheepPediatric Research, 2009
- Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newbornPediatric Critical Care Medicine, 2009
- Neonatal Ventilation with Inhaled Nitric Oxide vs. Ventilatory Support without Inhaled Nitric Oxide for Infants with Severe Respiratory Failure Born at or Near Term: The INNOVO Multicentre Randomised Controlled TrialNeonatology, 2006
- Nitric oxide for respiratory failure in infants born at or near termPublished by Wiley ,2006
- Neonatal Persistent Pulmonary Hypertension Treated with Milrinone: Four Case ReportsNeonatology, 2006
- Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle FunctionCirculation Research, 2003
- Increased expression of the cGMP‐inhibited cAMP‐specific (PDE3) and cGMP binding cGMP‐specific (PDE5) phosphodiesterases in models of pulmonary hypertensionBritish Journal of Pharmacology, 2002
- Inhaled nitric oxide in term and near-term infants: Neurodevelopmental follow-up of The Neonatal Inhaled Nitric Oxide Study Group (NINOS)The Journal of Pediatrics, 2000
- Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activityBritish Journal of Pharmacology, 1997